Pharmaniaga to work with China’s CSPC


PETALING JAYA: Pharmaniaga Bhd’s wholly-owned subsidiary Pharmaniaga LifeScience Sdn Bhd has signed a memorandum of understanding (MoU) with CSPC Holdings Co Ltd of China to collaborate in the research and development, manufacturing and commercialisation of pharmaceutical and biopharmaceutical products.

CSPC, a leading pharmaceutical group, has business segments of finished drugs and bulk drugs with innovative drugs as its core development strategy.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Pharmaniaga , CSPCHoldings , MoU

Next In Business News

China's 2025 copper imports lowest since 2020 amid major price rally
Trilateral links will boost growth
Strong growth for Malaysia's Islamic banking sector - S&P Global Ratings
Oil prices pause gains as Venezuela shipments resume but Iran concerns loom
Saks Global files for bankruptcy after Neiman Marcus takeover leads to financial collapse
Asian stocks inch higher, fragile yen spurs intervention worries�
FBM KLCI struggles to extend gains amid profit-taking pressure
China's trade ends 2025 with record trillion-dollar surplus despite Trump tariffs
Netflix prepares all-cash offer for Warner Bros, source says
Japan's Nikkei hits record high on loose policy hopes, weaker yen

Others Also Read